Products for Research Use Only

Docosatrienoic Acid

CAT: 0804-HY-101408-01Size: 5 mg (149 mM x 100 μL in Ethanol)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101408-01Size:5 mg (149 mM x 100 μL in Ethanol)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM.
CAS Number
28845-86-5
Product Name Alternative
Cis-13,16,19-docosatrienoic acid; (13Z,16Z,19Z) -13,16,19-Docosatrienoic acid
UNSPSC
12352211
Hazard Statement
H315, H319, H335, H413
Target
Endogenous Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Docosatrienoic_Acid.html
Concentration
149 mM * 100 μL in Ethanol
Purity
99.9
Solubility
Ethanol : 100 mg/mL (ultrasonic)
Smiles
CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(O)=O
Molecular Formula
C22H38O2
Molecular Weight
334.54
Precautions
H315, H319, H335, H413
References & Citations
[1]Yagaloff KA, et al. Essential fatty acids are antagonists of the leukotriene B4 receptor. Prostaglandins Leukot Essent Fatty Acids. 1995 May;52 (5) :293-7.|[2]Krutetskaia ZI, et al. The effect of docosatrienoic acid on the potassium channels of outward rectification in the membrane of rat peritoneal macrophages. Fiziol Zh Im I M Sechenova. 1995 Jul;81 (7) :111-9.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Natural Products
Clinical Information
No Development Reported